Skip to main content
  • DEVELOPMENT OF GASTRORETENTIVE FORMULATION OF ALPRAZOLAM

    About Authors:
    Pavitra Solanki1, Satyaveer Singh Solanki2
    1- Research Scholar, KIET school of Pharmacy, Ghaziabad.
    2- Asstt. Professor, Nehru Mahavidhyalaya, Lalitpur, Uttar Pradesh
    *pavitra.bpharma@gmail.com

    Abstract
    The goal in designing controlled floating delivery system to reduce the frequency of dosing and / or to increase effectiveness of drug by localization at the site of action, reducing the dose required or providing uniform drug delivery with high bioavailability of buoyant drugs and also reduce the severity and frequency of side effects by maintaining patient blood levels of the drug above the minimum effective level and below the minimum toxic level.
    Oral route has been the commonly adopted and most convenient route for drug administration. Oral route of administration has been received more attention in the pharmaceutical field because of the more flexibility in the designing of dosage form than drug delivery, design for other routes.  For sustained drug delivery dosing interval can be extended either by manipulating the drug molecule to reduce the rate of elimination or by altering the release rate of a dosage form to retard the rate of absorption. Both these approaches decrease fluctuating in plasma level in case of multiple dosing extending the dosing interval without under or over dosing.

  • Pharmaceutical Regulatory Agencies and Organizations around the World: Scope and Challenges in Drug Development

    About Authors:
    Geetanjali Sengar*, Pranab Tripathy

    Drug Regulatory Affairs Dept.
    Belco Pharma, 515, Modern Industrial Estate,
    Bahadurgarh-124507(Haryana), India.
    *geetanjali.sengar@gmail.com, geetanjalisengar87@gmail.com

    ABSTRACT:
    As the pharmaceutical industries throughout the world are moving ahead towards becoming more and more competitive, regulatory agencies are being established in various countries across the globe. Regulatory agencies and organizations play a vital role to meet the requirements of legal procedures related to drug development process in a country.

    In the present scenario, pharmaceuticals are considered as the most highly regulated industries worldwide. The regulatory body ensures compliances in various legal and regulatory aspects of a drug. Every country has its own regulatory authority, which is responsible to enforce the rules and regulations and issue the guidelines to regulate drug development process,licensing, registration, manufacturing, marketing and labeling of pharmaceutical products. USFDA(USA), MHRA(UK), TGA(Australia), CDSCO(India), HEALTH CANADA(CANADA), MCC(South Africa),ANVISA (Brazil) , EMEA (European Union), SFDA (China),NAFDAC(Nigeria), MEDSAFE(Newzeland), MHLW(Japan), MCAZ(Zimbabwe), SWISSMEDIC(Switzerland), KFDA(Korea), MoH (Sri Lanka) are the few regulatory  agencies and organizations established in respective countries.

  • CHEMISTRY AND COMMON SYNTHETIC ROUTE OF 1, 3, 4-OXADIAZOLE: AN IMPORTANT HETEROCYCLIC MOIETY IN MEDICINAL CHEMISTRY

    About Authors:
    Sukhbir L.Khokara1*, Naveen2, Jitendra2, Balram2, Dhirender2, Rajender Kumar1

    1Department of Pharmacy, Manav Bharti University, Solan (H.P.) 173229
    2Institute of pharmaceutical sciences, Kurukshetra University, Kurukshetra, Harayana-136119

    rajkaushal13@gmail.com

    ABSTRACT
    These heterocyclic moiety are prepared by different method and  have different biological and physiological properties. The widespread use of 1,3, 4 –oxadiazole as a scaffold in medicinal chemistry establishes this moiety as an important bioactive class of heterocyclic compounds. These compound have biological properties like anticonvulsant, analgesic, antipyretic, antimitotic,antitubercular and antimicrobial etc.

    [adsense:336x280:8701650588]

  • A REVIEW ARTICLE ON: GENERAL CONSIDERATIONS FOR CLINICAL TRIALS (ICH EFFICACY TOPIC E8) AND MARKETING AUTHORIZATION

    About Authors:
    Vinay K. Gupta*, G. Rajan and  Preeti Kothiyal
    Shree Guru Ram  Rai Institute of Technology  & Science,
    Patel Nagar, Dehradun
    *vngupta74@gmail.com

    Abstract
    The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry of Europe, Japan and the US to discuss scientific and technical aspects of drug registration. Since its inception in 1990, ICH has evolved, through its ICH Global Cooperation Group, to respond to the increasingly global face of drug development, so that the benefits of international harmonization for better global health can be realized worldwide. ICH's mission is to achieve greater harmonization to ensure that safe, effective and high quality medicines. This contains four main topic that are Quality, Safety, Efficacy and Multidisplinary. Here we are mainly explain general aspects of clinical trial that are related to ICH E8 and procedure for marketing authorization of new drug substance in India

  • REVIEW ARTICLE ON IN SITU GEL FORMING FOR OCCULAR DRUG DELIVERY SYSTEM

    About Authors:
    H. S. Sawwalakhe*, J. M. Maidankar, M. A. Channawar, Dr. A. V. Chandewar
    P. W. College of Pharmacy, Yavatmal,
    Amravati university

    *hemant_11sep@rediffmail.com

    ABSTRACT:
    Occular drug delivery is one of the most interesting and challenging endeavors facing the pharmaceutical scientists, the major problem encountered to pharmaceutical scientist is rapid precorneal elimination of the drug, resulting in poor bioavailability and therapeutic response, because of high tear fluid turnover and dynamics. In situ-forming gels are liquid upon instillation and undergo phase transition in the ocular cul de-sac to form visco-elastic gel and these gels provides a response to environmental changes. In the past few years, an impressive number of novel temperature, pH, and ion induced in situ-forming systems have been reported for sustained ophthalmic drug delivery. Each system has its own advantages and drawbacks. The choice of a particular gel depends on its intrinsic properties and envisaged therapeutic use. This review includes various temperature, pH, and ion induced in situ-forming polymeric systems used to achieve prolonged contact time of drugs with the cornea and increase their bioavailability Now a days in situ gel have been used as vehicles for the delivery of drugs for both local treatment and systemic effects. Different administration routes other than ocular have been explored, and these cutaneous and subcutaneous delivery, dental, buccal delivery and delivery to the esophagus, stomach, colon, rectum and vagina.

  • ALLICIN: AS A NOVEL PHYTOMOLECULE IN MODERN PHARMACY

    About Authors:
    Marvinkumar I. Patel*, Jyoti P. Patel, Ravi P. Patel, Hitesh P. Patel
    Nootan Pharmacy College,
    Visnagar, Gujarat

    *patel.marvin62@gmail.com

    Abstract:
    Allicin is a novel molecule obtain from garlic. It is a molecule which is biologically active and give a good activity again so many disease in the treatment. It has mainly the virtu of killing the microorganisms which can not be killed by the regular antibiotics. It is not widely used in the pharmafield till today but widely used as food supplement but it has a wide scope to use as a novel tool to treat gastric cancer and microbial infection.

  • Express Test and Nanovision Scan of Fiberglass Using a Nanoindenter

    About Authors:
    *Kaumudi Singh, Shrishti Saroha
    IIMT, Uttar Pradesh, India
    *kaumudisingh.info@gmail.com

    Abstract
    In this research work we actually try to determine elastic modulous and hardness of a fiberglass of a car .this is done by AFM-like scan and in this thermoplastic has shown elastic modulous 7.40 and hardness 0.43 and fiberglass shows 76.69 and hardness 7.90. In this article we concluded that fibre glass is more beneficial than thermoplastic,hence fiberglass are good for tranportation  of pharmaceuticles as I concluded.also as fibreglass is made up of glass it is inert with active ingredients also.

  • EVALUATION OF THE ASSOCIATION OF rs8052394 OF METALOTHIONEIN-1A GENE WITH TYPE 2 DIABETES MELLITUS IN NEPALESE POPULATION

    About Authors:
    Bishal Khatiwada1,2, Binita Dhakal1,2, Surya Prasad Sharma1,2, Uddhav Timilsina1
    1. Department of Biotechnology,
    College for Professional Studies, Kathmandu, Nepal
    2. Department of Biotechnology,
    Sikkim Manipal University, Gangtok, Sikkim, India
    *
    suryapdsharma@gmail.com

    Reference Id: PHARMATUTOR-ART-1310

    INTRODUCTION
    Diabetes mellitus is a metabolic disorder in which person is characterized by the high blood sugar either because the body does not produce enough insulin, or because cells do not use the insulin that is produced.[1] The classical symptoms of diabetes are polyuria (frequent urination), polydipsia (increased thirst) and polyphagia (increased hunger).[2] Almost one in 10 of the world population already has this condition, or can be expected to develop it during their lifetime, with prevalence rates forecast to double within the next 15 years.[3] According to WHO(2000A.D.), at least 171 million people worldwide suffer from diabetes, or 2.8% of the population.[4]

    [adsense:336x280:8701650588]

  • NEW ERA OF OCULAR THERAPY

    About Authors:
    Richa Thakur*, Gaurav Swami, M.S. Rathore, A.K. Sharma
    CT Institute of Pharmaceutical Sciences,
    Jalandhar, Punjab, India

    *thakur.richa89@gmail.com

    ABSTRACT
    The anatomy, physiology and biochemistry of the eye render this organ exquisitely impervious to foreign substances. The main challenge to the formulator is to circumvent the protective barriers of the eye without causing permanent tissue damage. The newly developed particulate and vesicular systems like liposomes, pharmacosomes and discosomes are useful in delivering the drug for a longer extent and helpful in reaching the systemic circulation. The most recent advancements of the ocular delivery systems provide the delivery of the genes and proteins to the internal structures which were once inaccessible and thus are of great importance in treating the diseases which are caused due to genetic mutation, failure in normal homeostasis, malignancy but also maintaining the physiological function of eye. The review focuses on the developments achieved in this mode of delivery of the drugs along with the pros and cons associated with greater focus on the advanced delivery systems.

  • AN OVERVIEW ON PRECLINICAL EVALUATION TECHNIQUES OF NOOTROPIC AGENTS

    ABOUT AUTHORS:
    Renu Singh*, Saumya Das, Sanjita Das
    Institute of Pharmaceutical Technology, NIET,
    Greater Noida, U.P., 201306.

    *renusingh2910@gmail.com

    ABSTRACT
    Cognitive deficits have long been recognized as severe and consistent neurological disorders associated with numerous psychiatric and neurodegenerative states such as Alzheimer’s disease. Dementia is one of the age-related mental problems, and a characteristic symptom of Alzheimer’s disease. Alzheimer’s disease (AD) is a progressive neurodegerative disorder which affects older individuals and may progress to a totally vegetative state. Atrophy of cortical and sub-cortical areas is associated with deposition of β-amyloid protein in the form of senile plaques and formation of neurofibrillary tangles. There is marked cholinergic deficiency in the brain, though other neurotransmitter systems are also affected. Various measures to augement cholinergic transmitter in the brain have been tried. The relatively cerebroselective anti-ChEs have been approved for clinical use. Nootropic agents are clinically used in situations where there is organic disorder in learning abilities and for improving memory, mood and behavior, but the resulting side-effects associated with these agents have made their utility limited. Many experimental models are currently available for the evaluation of agents that affect learning and memory processes. In-vitro methods inhibition of acetylcholinesterase activity is measured by determining IC50 with the help of Log probit analysis. In ex-vivo cholinesterase inhibition method the dose response relationship determined for drugs such as physostigmine and tacrine Agents which are H3 receptor agonist are evaluated for [3H] Ach release activity in rat using rat brain slices. The binding affinity of potential nicotinic cholinergic agonist in brain using agonist ligand is determined by [3H]-N- methyl carbamylcholine binding nicotinic cholinergic receptors in rat frontal cortex. In In-vivo methods the inhibitory passive avoidance the test are carried on animals to test the learning and memory capacity of animal by suppressing a particular behavior. It includes step down, step through, two compartment test, up-hill avoidance, scopolamine induced test, and ischemia induced amnesia, memory impairments in basal forebrain. In active avoidance conditioned stimulus is given to the animal, which gives noxious stimulus as a result. It includes runway avoidance, shuttle box avoidance, jumping avoidance. In discrimination learning animals have no choice between the conditioned stimuli. Studies on aged monkeys provides additional advantage for neurobehavioral animal model of aging in that many of behavioral processes thought to be affected by aging.

Subscribe to Articles